Sepsis complicated by acute lung injury (ALI) predisposes the host to a number of infectious complications (e.g. gram-negative nosocomial pneumonia). Mechanisms by which sepsis/ALI results in impairment in lung antibacterial host defenses have not been defined. Recent evidence indicates that specific cytokines, including T1-phenotype [interleukin-12 (IL-12) and interferon-gamma (IFN-gamma)] and T2-phenotype [interleukin-10 (IL-10)] cytokines, as well as the chemokine monocyte chemoattractant protein-1 (MCP-1), play an important role in modulating septic responses and are critical components of the innate immunity against bacterial pathogens. The focus of this proposal is to determine the effects of sepsis/ALI on cytokine-mediated lung antibacterial host defense. The hypothesis of Project 2 is that sepsis induced suppression of lung antibacterial host defense is the result of an altered balance in the expression of important pro- and anti-inflammatory cytokines, favoring the production of T2-, rather than T1-phenotype cytokines. Human subjects and murine models will be utilized to perform the following Specific Aims: I) To a) assess the effect of intra-abdominal sepsis (experimental cecal ligation and puncture) on murine alveolar macrophage cytokine expression and antimicrobial activity ex-vivo, and b) determine the effect of intra- abdominal sepsis on pro- and anti-inflammatory cytokine expression, lung inflammatory cell influx, bacterial clearance, and survival in a murine model of Pseudomonas aeruginosa pneumonia; III) to determine the contribution of endogenously-produced MCP-1 and IL-10 to sepsis-induced suppression of lung antibacterial host defense by neutralizing MCP-1 or IL-10 in mice with intra-abdominal sepsis during the development of Pseudomonas pneumonia; IV) to determine whether impaired production of IL- 12 and IFN-gamma contributes to sepsis induced suppression of lung antibacterial host defense by transiently over-expressing IL-12 and IFN- gamma within the lung in mice with intra-abdominal sepsis during the development of Pseudomonas pneumonia; and V) to a) assess the effect of ALI on human alveolar macrophage cytokine expression and antimicrobial activity ex vivo, and b) determine the effect of ex-vivo IL-10 and MCP-1 neutralization, or IFN-gamma administration on the ability to reverse sepsis-induced macrophage deactivation. These studies will provide insight into the development of novel treatment strategies to be employed in patients with ALI complicated by nosocomial pneumonia.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Specialized Center (P50)
Project #
1P50HL060289-01
Application #
6110952
Study Section
Project Start
1998-12-01
Project End
1999-11-30
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
1
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Type
DUNS #
791277940
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Bosmann, Markus; Grailer, Jamison J; Ruemmler, Robert et al. (2013) Extracellular histones are essential effectors of C5aR- and C5L2-mediated tissue damage and inflammation in acute lung injury. FASEB J 27:5010-21
Moss, Marc; Standiford, Theodore J (2011) Leptin in fibroproliferative acute respiratory distress syndrome: not just a satiety factor. Am J Respir Crit Care Med 183:1443-4
Smith, Monica R; Gangireddy, Srinivasa R; Narala, Venkata R et al. (2010) Curcumin inhibits fibrosis-related effects in IPF fibroblasts and in mice following bleomycin-induced lung injury. Am J Physiol Lung Cell Mol Physiol 298:L616-25
Keshamouni, Venkateshwar G; Jagtap, Pratik; Michailidis, George et al. (2009) Temporal quantitative proteomics by iTRAQ 2D-LC-MS/MS and corresponding mRNA expression analysis identify post-transcriptional modulation of actin-cytoskeleton regulators during TGF-beta-Induced epithelial-mesenchymal transition. J Proteome Res 8:35-47
Reddy, Raju C; Srirangam, Anjaiah; Reddy, Kaunteya et al. (2008) Chemotherapeutic drugs induce PPAR-gamma expression and show sequence-specific synergy with PPAR-gamma ligands in inhibition of non-small cell lung cancer. Neoplasia 10:597-603
Reddy, Raju C; Narala, Venkata R; Keshamouni, Venkateshwar G et al. (2008) Sepsis-induced inhibition of neutrophil chemotaxis is mediated by activation of peroxisome proliferator-activated receptor-{gamma}. Blood 112:4250-8
Milam, Jami E; Keshamouni, Venkateshwar G; Phan, Sem H et al. (2008) PPAR-gamma agonists inhibit profibrotic phenotypes in human lung fibroblasts and bleomycin-induced pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 294:L891-901
Gomperts, Brigitte N; Belperio, John A; Fishbein, Michael C et al. (2007) Keratinocyte growth factor improves repair in the injured tracheal epithelium. Am J Respir Cell Mol Biol 37:48-56
Keshamouni, Venkateshwar G; Michailidis, George; Grasso, Catherine S et al. (2006) Differential protein expression profiling by iTRAQ-2DLC-MS/MS of lung cancer cells undergoing epithelial-mesenchymal transition reveals a migratory/invasive phenotype. J Proteome Res 5:1143-54
Gomperts, Brigitte N; Belperio, John A; Rao, P Nagesh et al. (2006) Circulating progenitor epithelial cells traffic via CXCR4/CXCL12 in response to airway injury. J Immunol 176:1916-27

Showing the most recent 10 out of 88 publications